An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period

Main Article Content

Andrea Zaenglein
James Del Rosso


acne, nodular acne, lidose-isotretinoin, retinoid


Abstract not available.


Disclosures: Study supported by SUN Pharma.


Copyright 2018 SKIN

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>